BrightInsight, a Flex Company, provides the leading global regulated digital health platform for biopharma and medtech. Our medical-grade Internet of Things (IoT) platform is built under a Quality Management System to support and optimize regulated drugs, devices and software through integrated data and actionable insights to enable customers to drive increased patient adherence and engagement.
The BrightInsight™ Platform uses software and services to capture, transmit and analyze data from CE-marked and FDA-regulated medical devices, combination products, apps and Software as a Medical Device, in compliance with security, privacy and regulatory requirements.
Ieso Digital Health is a biotechnology company whose mission it is to harness advanced technology and clinical science to deepen the understanding of the causes, symptoms and treatments of mental health problems.
By delivering psychological care to patients using the Ieso online therapy platform, a combination of data science, and advanced analytics can be used to develop digital therapeutics, education and training, and AI tools, to change the way mental healthcare is delivered across the world.
Ieso’s employees are dedicated to building a new paradigm in mental health science; building a complete understanding of the root causes of mental health conditions and developing interventions that will address the personal, societal and economic impacts of mental illness, paving the way for a world where everyone has access to the help they need, when they need it.
TopLine Power® is what Simon-Kucher is all about. We help clients grow revenue through optimization of strategy, pricing, marketing, and sales across industries.
We are a thought leader in these topics at the intersection of digitalization and life sciences, positioning our clients thrive in the healthcare industry of the future.
RB* is a leading global health company inspired by a vision of the world where people are healthier and live better. Its purpose is to make a difference by giving people innovative solutions for healthier lives and happier homes. RB has operations in over 60 countries and its products reach millions of people globally every day. Its trusted health brands include names such as Enfamil, Nutramigen, Nurofen, Strepsils, Gaviscon, Mucinex, Durex, Scholl, Dettol and Veet. RB’s drive to achieve, passion to outperform and commitment to quality and scientific excellence is manifested in the work of over 40,000 diverse, talented entrepreneurs worldwide. For more information visit www.rb.com/innovation. *RB is the trading name of the Reckitt Benckiser group of companies
Biorasi is an award-winning, full-service, global CRO that optimizes the design and delivery of clinical trials for its sponsors, powered by our proprietary TALOS™ system. Since 2002, Biorasi has achieved success in bringing innovative therapies to market for our sponsors with better patient recruitment, powerful data insights, and operational excellence.
Medisafe is the leading medication management platform addressing non-adherence challenges with a clinically validated solution. Our digital health companion makes the management of even the most complex drug regimens possible. Data powered technology delivers personalized interventions based on behavioral insights keeping patients engaged and adherent in their therapeutic needs.
BHealth Catalyst, Inc. is a next-generation data, analytics, and decision-support company, committed to being a catalyst for massive, sustained improvements in healthcare outcomes. Through its outcomes-oriented approach, Health Catalyst aligns the needs of healthcare organizations, patients, and life sciences. Life sciences research, development, and launch efforts can now become patient-centered and outcomes-oriented by leveraging Health Catalyst’s trusted network of integrated delivery networks (IDNs), consisting of over 100 million patients and encompassing over 1 trillion facts. The future of real-world evidence depends on reinforcing feedback loops that drive real-world action—including running pragmatic studies, developing and implementing machine learning models in care environment, and novel outcomes-based reimbursement approaches.
IQVIA (NYSE:IQV) is a leading global provider of information, innovative technology solutions and contract research services focused on helping healthcare clients find better solutions for patients. Formed through the merger of IMS Health and Quintiles, IQVIA applies Human Data Science — leveraging the analytic rigor and clarity of data science to the ever-expanding scope of human science — to enable companies to reimagine and develop new approaches to clinical development and commercialization, speed innovation and accelerate improvements in healthcare outcomes.
Click Therapeutics, Inc. develops and commercializes software as prescription medical treatments for people with unmet medical needs. Through cognitive and neurobehavioral mechanisms, Click’s Digital Therapeutics™ enable change within individuals and are designed to be used independently or in conjunction with biomedical treatments. The Clickometrics® adaptive data science platform continuously personalizes user experience to optimize engagement and outcomes.
Following a groundbreaking clinical trial, Click’s industry-leading smoking cessation program is available nationwide through a wide variety of payers, providers, and employers. Click’s lead prescription program is entering into a multi-center, randomized, controlled, parallel-group, phase III FDA registration trial for the treatment of Major Depressive Disorder in adults.
JAZZ Venture Partners invests in companies that extend the boundaries of human performance — improving how we live, learn, work, play, and experience the world.
We seek breakthroughs at the intersection of digital technology and neuroscience that are influencing the human experience, such as augmented reality, artificial intelligence, immersive gaming, and closed-loop human-computer systems.
Our portfolio companies are unlocking human potential in health, mind-body wellness, accelerated learning and training, sports, entertainment, and the enterprise.
Cognoa’s digital diagnostics and personalized therapeutics improve the timeliness, scale, and effectiveness of behavioral healthcare. Their first clinically-validated mobile application identified autism on average 13 months earlier than the national average and as early as 18 months – when early intervention has the greatest potential for improved life-long outcomes.
Otsuka Pharmaceutical is a global healthcare company with the corporate philosophy: “Otsuka-people creating new products for better health worldwide.” Otsuka researches, develops, manufactures and markets innovative products, with a focus on pharmaceutical products for the treatment of diseases and nutraceutical products for the maintenance of everyday health.